| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180934 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 09/16/2004 | US20040180915 Methadone-containing compositions for parenteral administration and method of use thereof |
| 09/16/2004 | US20040180914 5-Cyano-2-aminopyrimidine derivatives |
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180899 tyrosine kinase inhibitors |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180876 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis |
| 09/16/2004 | US20040180834 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 09/16/2004 | US20040180832 Sustained peptide-release formulation |
| 09/16/2004 | CA2796381A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 09/16/2004 | CA2518193A1 Use of ep2 selective receptor agonists in medical treatment |
| 09/16/2004 | CA2517974A1 Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
| 09/15/2004 | EP1457212A1 Eye drops |
| 09/15/2004 | EP1457205A1 Angiogenesis inhibitor |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456354A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
| 09/15/2004 | EP1456246A1 Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 09/15/2004 | EP1456219A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456201A1 Benzhydryl derivatives |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455837A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455804A2 Use of nanoparticles as carriers for biocides in ophthalmic compositions |
| 09/15/2004 | EP1455803A1 Pharmaceutical composition for use in ophthalmology and rhinology |
| 09/15/2004 | EP1455795A1 Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 09/15/2004 | EP1455794A2 PHARMACEUTICAL COMPOSITION COMPRISING A ClC-2 CHANNEL OPENER |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455780A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 09/15/2004 | EP1455750A1 Viscoelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulphate |
| 09/15/2004 | EP1455734A1 Compositions comprising phenyl-glycine derivatives |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP0841937B1 Use of betaglycan to reduce scarring |
| 09/15/2004 | EP0671910B1 Use of adamantane derivatives for the manufacture of a medicament in the TREATMENT of glaucoma |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529620A Otic microbial compositions for treating animal with raptured tympanic membrane |
| 09/15/2004 | CN1529598A Method of treating demyelinating diseases or conditions |
| 09/15/2004 | CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| 09/15/2004 | CN1529594A Injectable galenic formulation for use in diagnosis or photodynamic therapy and method for preparing same |
| 09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
| 09/15/2004 | CN1528434A Chinese medicine composition for treating myopia and preparing method thereof |
| 09/15/2004 | CN1528410A Chinese medicine for treating eye disease and preparing method thereof |
| 09/15/2004 | CN1528368A Powder for treating eye disease and preparing method thereof |
| 09/15/2004 | CN1528346A Oculentum for treating eye disease and preparing method thereof |
| 09/15/2004 | CN1528342A Electrooptical eye drops for preventing and treating electric ophthalmia |
| 09/15/2004 | CN1528305A Radix sen rhizoma fibraureae extract drop pill and preparing method thereof |
| 09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
| 09/15/2004 | CN1166658C 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors |
| 09/15/2004 | CN1166643C 4-phenyl-pyrimidine derivatives |
| 09/15/2004 | CN1166372C Formula of medicine for treating myopia and preparation process thereof |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790859 Therapy or reducing progression of hypertension or damage to a tissue caused by contact with elevated levels of reducing sugars in an animal, comprising administering to the animal an effective amount of thiazolium compounds |
| 09/14/2004 | US6790447 Peptides for treatment of autoimmune diseases |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/14/2004 | CA2130115C Prevention of retinal injury and degeneration by specific factors |
| 09/10/2004 | WO2004076626A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 09/10/2004 | WO2004076491A1 Medicinal composition for ophthal use containing acetylated hyaluronic acid |
| 09/10/2004 | WO2004076476A1 Glycopeptide and use thereof as proteoglycan initiator |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004075895A1 Ocular hypotensive agent |
| 09/10/2004 | WO2004075888A1 Remedy for corneal ulcer |
| 09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2004009030A3 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | CA2514781A1 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040176749 Insert for the treatment of dry eye |
| 09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
| 09/09/2004 | US20040176455 Deprenyl compounds for treatment of glaucoma |
| 09/09/2004 | US20040176443 Capsaicin receptor ligands |
| 09/09/2004 | US20040176436 Tryptophanyl-esters and their N-acyl derivatives for preventing and treating diseases caused or aggravated by oxidation processes |
| 09/09/2004 | US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176362 Matrix metalloproteinase inhibitors, treatment of tumor necrosis factor mediated diseases; autoimmune and neurodegenerative disorders; anticarcinogenic and antiinflammatory agents |
| 09/09/2004 | US20040176333 2-Mercaptopropionamide derivatives; |
| 09/09/2004 | US20040176286 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/08/2004 | EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |